Cannabis and Blood Pressure
What the evidence actually says about cannabis, cannabinoids, and hypertension — separating signal from marketing.
Cannabis is not a blood pressure medication. Acute THC use causes a short-term blood pressure spike followed by a drop, plus a fast heart rate — which is why heavy users have measurably higher cardiovascular event rates. CBD shows a modest acute blood pressure reduction in small studies, but no one has proven it treats hypertension long-term. If you have high blood pressure, the honest answer is: use evidence-based medications and lifestyle changes. Cannabis might not be off-limits, but it isn't therapy.
Not Medical Advice
This article is educational, not medical advice. Blood pressure is a serious clinical issue. If you have hypertension, suspected hypertension, or any cardiovascular disease, talk to a licensed clinician before changing how you use cannabis, CBD, or any prescribed medication. Do not stop antihypertensive drugs based on anything you read here.
Plain-Language Summary
When you smoke, vape, or eat THC-containing cannabis, your blood pressure and heart rate respond in a predictable pattern: blood pressure usually rises briefly, heart rate climbs noticeably (often 20–50 beats per minute above baseline), and then blood pressure can drop, especially when you stand up Strong evidence [1][2]. This effect fades within hours in occasional users, and tolerance partially develops in regular users Weak / limited [2].
CBD (cannabidiol), the non-intoxicating cannabinoid, behaves differently. A small but well-conducted study found a single 600 mg oral dose modestly lowered resting and stress-induced blood pressure in healthy men Weak / limited [3]. That is one acute study in nine people — not proof that CBD treats hypertension.
Observational studies of heavy, long-term cannabis users show higher rates of heart attack, stroke, and cardiovascular mortality compared with non-users Strong evidence [4][5]. Whether this is caused by blood pressure effects, combustion products, tachycardia, or something else is not fully sorted out.
What Probably Works (Stronger Evidence)
Honestly: nothing in cannabis is a proven blood pressure treatment. No cannabis product has been shown in adequately powered randomized trials to lower blood pressure in hypertensive patients over the long term No data.
The closest thing to a real signal is acute CBD dosing in small studies, but "acute BP reduction in healthy volunteers" is not the same as "treats hypertension." Many things lower BP acutely (a hot bath, a beer, a nap) without being clinical treatments Strong evidence.
What Might Work (Weak / Emerging Evidence)
CBD, acutely. Jadoon et al. (2017) gave nine healthy men 600 mg oral CBD in a crossover trial. CBD reduced resting systolic BP by about 6 mmHg and blunted the BP response to stress Weak / limited [3]. Limitations: tiny sample, healthy subjects, single dose, no hypertensive patients, no long-term data.
CBD over weeks in hypertensive patients. A 2020 small study suggested 24 hours and 7 days of CBD dosing produced modest BP changes Weak / limited [6]. Again — small, short, not definitive.
Endocannabinoid system involvement in BP regulation. Animal and mechanistic work shows CB1 and CB2 receptors influence vascular tone and the renin–angiotensin system Weak / limited [7]. This is biologically interesting but does not translate directly into a treatment recommendation.
What Doesn't Work / Folklore
- "Cannabis lowers blood pressure." This is a half-truth that ignores the acute spike, the tachycardia, and the lack of long-term hypertensive trials Disputed.
- "Indica strains are good for blood pressure." The indica/sativa distinction does not reliably predict pharmacological effects on the cardiovascular system No data. See Indica vs Sativa.
- "CBD is a natural ACE inhibitor / replaces my BP meds." No. There is no clinical evidence supporting CBD as a substitute for antihypertensives No data.
- "Smoking weed is heart-healthy." Inhaled combustion products plus tachycardia plus BP swings are not a cardiovascular tonic Strong evidence.
What We Don't Know
- Whether daily CBD over months or years produces a clinically meaningful, sustained BP reduction in hypertensive patients No data.
- The optimal dose, formulation, and timing of CBD for any cardiovascular endpoint No data.
- How cannabis interacts with common antihypertensives (beta blockers, ACE inhibitors, calcium channel blockers, diuretics) at the level of patient outcomes — though pharmacokinetic interactions via CYP450 enzymes are documented Weak / limited [8].
- Whether tolerance fully protects chronic users from the cardiovascular event risk seen in observational studies Weak / limited.
- Whether minor cannabinoids (CBG, CBDV, THCV) have meaningful cardiovascular effects in humans No data.
Comparison With Standard Treatments
Standard antihypertensive therapy — thiazide diuretics, ACE inhibitors, ARBs, calcium channel blockers, beta blockers — is supported by decades of large randomized trials showing reductions in stroke, heart attack, and mortality Strong evidence [9]. Lifestyle interventions (DASH diet, sodium reduction, weight loss, exercise, reduced alcohol) also have strong outcome data Strong evidence [9].
No cannabis product has comparable outcome data. Even the most generous reading of the CBD literature puts it in the "interesting hypothesis, needs real trials" category — not in the same conversation as licensed antihypertensives.
If you are using cannabis recreationally and also have hypertension, the practical question is risk management (see below), not substitution.
Risks
- Acute cardiovascular stress. THC reliably increases heart rate and can cause BP swings. In people with existing coronary disease, this raises myocardial oxygen demand and has been linked to a transient increase in heart attack risk in the hour after use Strong evidence [10].
- Orthostatic hypotension. Standing up after dosing — especially edibles or higher-THC products — can cause dizziness or fainting Strong evidence [2].
- Stroke risk. Heavy and frequent cannabis use is associated with increased stroke risk in observational data, particularly in younger users Strong evidence [5].
- Drug interactions. CBD inhibits several CYP450 enzymes and can raise levels of some cardiovascular drugs (e.g., certain beta blockers, calcium channel blockers, warfarin) Strong evidence [8]. This is a real, documented interaction class — not theoretical.
- Synthetic cannabinoids ("K2/Spice") cause severe, unpredictable cardiovascular events and should not be confused with cannabis Strong evidence.
If you have hypertension, coronary artery disease, arrhythmia, or a history of stroke: discuss any cannabis use with your clinician, prefer non-combusted routes, start low, and do not stop your prescribed medications.
Sources
- Peer-reviewed Sidney, S. (2002). Cardiovascular consequences of marijuana use. Journal of Clinical Pharmacology, 42(S1), 64S–70S.
- Peer-reviewed Jones, R. T. (2002). Cardiovascular system effects of marijuana. Journal of Clinical Pharmacology, 42(S1), 58S–63S.
- Peer-reviewed Jadoon, K. A., Tan, G. D., & O'Sullivan, S. E. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight, 2(12), e93760.
- Peer-reviewed Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001). Triggering myocardial infarction by marijuana. Circulation, 103(23), 2805–2809.
- Peer-reviewed Hemachandra, D., McKetin, R., Cherbuin, N., & Anstey, K. J. (2016). Heavy cannabis users at elevated risk of stroke: evidence from a general population survey. Australian and New Zealand Journal of Public Health, 40(3), 226–230.
- Peer-reviewed Sultan, S. R., Millar, S. A., England, T. J., & O'Sullivan, S. E. (2017). A systematic review and meta-analysis of the haemodynamic effects of cannabidiol. Frontiers in Pharmacology, 8, 81.
- Peer-reviewed Pacher, P., Bátkai, S., & Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews, 58(3), 389–462.
- Peer-reviewed Brown, J. D., & Winterstein, A. G. (2019). Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine, 8(7), 989.
- Government Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension, 71(6), e13–e115.
- Peer-reviewed DeFilippis, E. M., Bajaj, N. S., Singh, A., et al. (2020). Marijuana use in patients with cardiovascular disease: JACC Review Topic of the Week. Journal of the American College of Cardiology, 75(3), 320–332.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.